BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stastny I, Zubor P, Kajo K, Kubatka P, Golubnitschaja O, Dankova Z. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer. Clin Breast Cancer 2020;20:e711-22. [PMID: 32792225 DOI: 10.1016/j.clbc.2020.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ciccarelli FD, DeGregori J. Approaching Cancer Evolution from Different Angles. iScience 2020;23:101661. [PMID: 33134891 DOI: 10.1016/j.isci.2020.101661] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zhang JT, Chen J, Ruan HC, Li FX, Pang S, Xu YJ, Huang DL, Wu XH. Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4. Cancer Manag Res 2021;13:8425-34. [PMID: 34785950 DOI: 10.2147/CMAR.S333830] [Reference Citation Analysis]
3 Liskova A, Samec M, Koklesova L, Giordano FA, Kubatka P, Golubnitschaja O. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management. J Clin Med 2020;9:E2749. [PMID: 32854390 DOI: 10.3390/jcm9092749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
4 Pös Z, Pös O, Styk J, Mocova A, Strieskova L, Budis J, Kadasi L, Radvanszky J, Szemes T. Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes. Int J Mol Sci 2020;21:E8634. [PMID: 33207777 DOI: 10.3390/ijms21228634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J 2020;:1-25. [PMID: 33144898 DOI: 10.1007/s13167-020-00226-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
6 Wu HJ, Chu PY. Current and Developing Liquid Biopsy Techniques for Breast Cancer. Cancers (Basel) 2022;14:2052. [PMID: 35565189 DOI: 10.3390/cancers14092052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kunin A, Sargheini N, Birkenbihl C, Moiseeva N, Fröhlich H, Golubnitschaja O. Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies. EPMA J 2020;:1-11. [PMID: 33200009 DOI: 10.1007/s13167-020-00229-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Piskór BM, Przylipiak A, Dąbrowska E, Sidorkiewicz I, Niczyporuk M, Szmitkowski M, Ławicki S. Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer. J Clin Med 2020;9:E4122. [PMID: 33371324 DOI: 10.3390/jcm9124122] [Reference Citation Analysis]
9 Koklesova L, Liskova A, Samec M, Zhai K, Al-Ishaq RK, Bugos O, Šudomová M, Biringer K, Pec M, Adamkov M, Hassan STS, Saso L, Giordano FA, Büsselberg D, Kubatka P, Golubnitschaja O. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention. Int J Mol Sci 2021;22:8649. [PMID: 34445360 DOI: 10.3390/ijms22168649] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Seale KN, Tkaczuk KHR. Circulating Biomarkers in Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00264-0. [PMID: 34756687 DOI: 10.1016/j.clbc.2021.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Kerachian MA, Azghandi M, Mozaffari-Jovin S, Thierry AR. Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA. Clin Epigenetics 2021;13:193. [PMID: 34663458 DOI: 10.1186/s13148-021-01182-7] [Reference Citation Analysis]